InsidersTradesSigma
Follow the RADIOPHARM THERANOSTICS LIMITED stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €39m. The latest transaction was reported on 24 August 2026 (Cease Substantial Holding). Among the most active insiders: 129 188 450 REGAL PARTNERS LIMITED. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
RADIOPHARM THERANOSTICS LIMITED is a company focused on the development of radiopharmaceutical therapies. It is listed on the XASX market.